News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,766 Results
Type
Article (63911)
Company Profile (291)
Press Release (684564)
Multimedia
Podcasts (58)
Webinars (12)
Section
Business (212106)
Career Advice (2373)
Deals (36249)
Drug Delivery (101)
Drug Development (84420)
Employer Resources (178)
FDA (16569)
Job Trends (15519)
News (358411)
Policy (33868)
Tag
Academia (2920)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (88)
Alliances (52658)
ALS (93)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (132)
Approvals (16565)
Artificial intelligence (272)
Autoimmune disease (23)
Automation (16)
Bankruptcy (366)
Best Places to Work (11956)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (198)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (285)
Cancer (2324)
Cardiovascular disease (181)
Career advice (1981)
Career pathing (32)
CAR-T (158)
Cell therapy (446)
Cervical cancer (20)
Clinical research (68097)
Collaboration (877)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2770)
CRISPR (43)
C-suite (255)
Cystic fibrosis (104)
Data (2237)
Decentralized trials (2)
Denatured (21)
Depression (48)
Diabetes (276)
Diagnostics (6584)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (87682)
Editorial (44)
Employer branding (22)
Employer resources (153)
Events (116577)
Executive appointments (750)
FDA (17852)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (785)
Gene editing (109)
Generative AI (23)
Gene therapy (320)
GLP-1 (748)
Government (4644)
Grass and pollen (5)
Guidances (67)
Healthcare (19579)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (30)
Infectious disease (2919)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (404)
IPO (16754)
IRA (44)
Job creations (3987)
Job search strategy (1683)
Kidney cancer (10)
Labor market (38)
Layoffs (497)
Leadership (19)
Legal (8190)
Liver cancer (77)
Lung cancer (328)
Lymphoma (155)
Machine learning (7)
Management (61)
Manufacturing (318)
MASH (70)
Medical device (13663)
Medtech (13668)
Mergers & acquisitions (20038)
Metabolic disorders (707)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (2014)
NextGen: Class of 2025 (6818)
Non-profit (4846)
Now hiring (39)
Obesity (374)
Opinion (224)
Ovarian cancer (76)
Pain (91)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (22)
Patents (237)
Patient recruitment (113)
Peanut (48)
People (59961)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (21245)
Phase II (29869)
Phase III (22191)
Pipeline (1218)
Policy (150)
Postmarket research (2935)
Preclinical (9567)
Press Release (70)
Prostate cancer (109)
Psychedelics (33)
Radiopharmaceuticals (258)
Rare diseases (393)
Real estate (6455)
Recruiting (67)
Regulatory (23168)
Reports (46)
Research institute (2626)
Resumes & cover letters (391)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (73)
Series A (135)
Series B (85)
Service/supplier (17)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3819)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (43)
The Weekly (35)
Vaccines (745)
Venture capitalists (41)
Weight loss (247)
Women's health (36)
Worklife (17)
Date
Today (38)
Last 7 days (915)
Last 30 days (2631)
Last 365 days (33419)
2025 (11004)
2024 (36094)
2023 (41044)
2022 (52322)
2021 (56939)
2020 (55621)
2019 (48440)
2018 (36556)
2017 (33775)
2016 (33762)
2015 (40364)
2014 (34260)
2013 (30419)
2012 (32020)
2011 (32394)
2010 (30970)
Location
Africa (878)
Alabama (55)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (41488)
Australia (7246)
California (6211)
Canada (2034)
China (540)
Colorado (269)
Connecticut (279)
Delaware (151)
Europe (93092)
Florida (920)
Georgia (211)
Idaho (58)
Illinois (560)
India (27)
Indiana (312)
Iowa (11)
Japan (166)
Kansas (107)
Kentucky (25)
Louisiana (10)
Maine (62)
Maryland (911)
Massachusetts (4656)
Michigan (220)
Minnesota (404)
Mississippi (2)
Missouri (82)
Montana (30)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1752)
New Mexico (31)
New York (1778)
North Carolina (1031)
North Dakota (9)
Northern California (2705)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1390)
Puerto Rico (12)
Rhode Island (33)
South America (1240)
South Carolina (24)
South Dakota (1)
Southern California (2329)
Tennessee (103)
Texas (924)
United States (23582)
Utah (186)
Virginia (152)
Washington D.C. (66)
Washington State (564)
West Virginia (3)
Wisconsin (57)
748,766 Results for "mannin research inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025
March 12, 2025
·
4 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Press Releases
Arizona Biosciences Set Record Highs in Research Funding, Show Increasing Competitiveness
April 23, 2025
·
3 min read
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
Press Releases
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025
April 25, 2025
·
4 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Impact Fusion International Inc. (OTC Pink: IFUS) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun.
May 13, 2024
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
1 of 74,877
Next
